Cargando…

A self-controlled case series to assess the effectiveness of beta blockers for heart failure in reducing hospitalisations in the elderly

BACKGROUND: To determine the suitability of using the self-controlled case series design to assess improvements in health outcomes using the effectiveness of beta blockers for heart failure in reducing hospitalisations as the example. METHODS: The Australian Government Department of Veterans' A...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ramsay, Emmae N, Roughead, Elizabeth E, Ewald, Ben, Pratt, Nicole L, Ryan, Philip
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2011
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3161026/ https://www.ncbi.nlm.nih.gov/pubmed/21762536 http://dx.doi.org/10.1186/1471-2288-11-106

Ejemplares similares

Proton pump inhibitors and the risk of pneumonia: a comparison of cohort and self-controlled case series designs
por: Ramsay, Emmae N, et al.
Publicado: (2013)

Ranibizumab and Risk of Hospitalisation for Ischaemic Stroke and Myocardial Infarction in Patients with Age-Related Macular Degeneration: A Self-Controlled Case-Series Analysis
por: Pratt, Nicole L., et al.
Publicado: (2014)

Association between Ophthalmic Timolol and Hospitalisation for Bradycardia
por: Pratt, Nicole L., et al.
Publicado: (2015)

Persistence with opioids post discharge from hospitalisation for surgery in Australian adults: a retrospective cohort study
por: Roughead, Elizabeth Ellen, et al.
Publicado: (2019)

The association between exacerbation of chronic obstructive pulmonary disease and timing of paracetamol use: a cohort study in elderly Australians
por: Kelly, Thu-Lan, et al.
Publicado: (2022)

Use of health services and medicines amongst Australian war veterans: a comparison of young elderly, near centenarians and centenarians
por: Roughead, Elizabeth E, et al.
Publicado: (2010)

Poor tolerance of beta-blockers by elderly patients with heart failure
por: Yanagisawa, Satoshi, et al.
Publicado: (2010)

Beta-blocker therapy in elderly patients with renal dysfunction and heart failure
por: Martínez-Milla, Juan, et al.
Publicado: (2021)

Bridging evidence-practice gaps: improving use of medicines in elderly Australian veterans
por: Roughead, Elizabeth E, et al.
Publicado: (2013)

Reducing opioid use for chronic non-cancer pain in primary care using an evidence-based, theory-informed, multistrategic, multistakeholder approach: a single-arm time series with segmented regression
por: Moffat, Anna K, et al.
Publicado: (2023)

Beta-Blockers and Oxidative Stress in Patients with Heart Failure
por: Nakamura, Kazufumi, et al.
Publicado: (2011)

New advances in beta-blocker therapy in heart failure
por: Barrese, Vincenzo, et al.
Publicado: (2013)

Self-Reported and Actual Beta-Blocker Prescribing for Heart Failure Patients: Physician Predictors
por: Sinha, Sanjai, et al.
Publicado: (2009)

Association Between Use of Multiple Psychoactive Medicines and Hospitalization for Falls: Retrospective Analysis of a Large Healthcare Claim Database
por: Pratt, Nicole L., et al.
Publicado: (2014)

Leukocyte Redistribution: Effects of Beta Blockers in Patients with Chronic Heart Failure
por: von Haehling, Stephan, et al.
Publicado: (2009)

The effect of beta-blockers in acute heart failure according to heart rate
por: Kim, Hyun-Jin, et al.
Publicado: (2021)

Choice of observational study design impacts on measurement of antipsychotic risks in the elderly: a systematic review
por: Pratt, Nicole, et al.
Publicado: (2012)

The validity of the Rx-Risk Comorbidity Index using medicines mapped to the Anatomical Therapeutic Chemical (ATC) Classification System
por: Pratt, Nicole L, et al.
Publicado: (2018)

Comparative effectiveness and safety of low-strength and high-strength direct oral anticoagulants compared with warfarin: a sequential cohort study
por: Pratt, Nicole L, et al.
Publicado: (2019)

Increased Risk of Heart Failure in Elderly Patients Treated with Beta-Blockers After AV Node Ablation
por: Bertomeu-Gonzalez, Vicente, et al.
Publicado: (2023)

Beta Blockers in Heart Failure: More Evidence for an Old Friend
por: Baek, Sang Hong
Publicado: (2018)

Treatment optimization of beta-blockers in chronic heart failure therapy
por: Niriayo, Yirga Legesse, et al.
Publicado: (2020)

Effects of Holding Beta-Blockers on the Vital Signs of Heart Failure Patients
por: Erickson, Marc, et al.
Publicado: (2021)

Beta-blockers and mechanical dyssynchrony in heart failure assessed by radionuclide ventriculography
por: Jones, K. A., et al.
Publicado: (2022)

Reducing hypnotic use in insomnia management among Australian veterans: results from repeated national interventions
por: Kalisch Ellett, Lisa M., et al.
Publicado: (2018)

Implementation and Evaluation of a Digitally Enabled Precision Public Health Intervention to Reduce Inappropriate Gabapentinoid Prescription: Cluster Randomized Controlled Trial
por: Andrade, Andre Q, et al.
Publicado: (2022)

A Review of the External Validity of Clinical Trials with Beta-Blockers in Heart Failure
por: Iyngkaran, Pupalan, et al.
Publicado: (2016)

The Impact of Treatment with Beta-Blockers upon Mortality in Chronic Heart Failure Patients
por: Taneva, Borjanka, et al.
Publicado: (2016)

Beta-blocker Therapy at Discharge in Patients with Acute Heart Failure and Atrial Fibrillation
por: Ahn, Min-Soo, et al.
Publicado: (2020)

Beta-blocker treatment in heart failure patients with atrial fibrillation: challenges and perspectives
por: Chourdakis, Emmanouil, et al.
Publicado: (2021)

Using machine learning to uncover heterogeneity of beta blocker response in heart failure
por: Tison, Geoffrey H.
Publicado: (2022)

Effectiveness and safety of four different beta‐blockers in patients with chronic heart failure
por: Liu, Baoshan, et al.
Publicado: (2023)

Resting heart rate in ambulatory heart failure with reduced ejection fraction treated with beta‐blockers
por: Varian, Kenneth D., et al.
Publicado: (2020)

β blockers for heart failure
por: Hoes, Arno W
Publicado: (2016)

Disease-modifying medications in heart failure: more than ACE inhibitors and beta blockers
por: Chao, Chia-Ter
Publicado: (2011)

Intravenous levosimendan vs. dobutamine in acute decompensated heart failure patients on beta-blockers
por: Bergh, Claes-Håkan, et al.
Publicado: (2010)

Individual patient data meta-analysis of beta-blockers in heart failure: rationale and design
por: Kotecha, Dipak, et al.
Publicado: (2013)

Effects of Beta-Blockers on Heart Failure with Preserved Ejection Fraction: A Meta-Analysis
por: Liu, Feng, et al.
Publicado: (2014)

Beta-blockers in heart failure prognosis: Lessons learned by MECKI Score Group papers
por: Cattadori, Gaia, et al.
Publicado: (2020)

Implication of Ivabradine in Up-titrating Beta-blocker in a Patient with Advanced Heart Failure
por: Hori, Masakazu, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_0o8947nov2uus72er6u553mci4